{"slideshow_credits": null, "snippet": "The lawsuit says the high price of the treatment, $1,000 per pill, results in &#8220;unjust enrichment&#8221; for the drugmaker, violating antitrust law.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/12/11/business/philadelphia-transit-agency-sues-gilead-over-cost-of-sovaldi.html", "lead_paragraph": "The lawsuit says the high price of the treatment, $1,000 per pill, results in &#8220;unjust enrichment&#8221; for the drugmaker, violating antitrust law.", "headline": {"main": "Philadelphia Transit Agency Sues Gilead Over Cost of Sovaldi", "print_headline": "Philadelphia Transit Agency Sues Gilead Over Cost of Sovaldi"}, "_id": "5488ecb638f0d82a671231ff", "word_count": "121", "multimedia": [], "pub_date": "2014-12-11T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Gilead Sciences Inc", "name": "organizations", "is_major": "N", "rank": "1"}, {"value": "Sovaldi (Drug)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Hepatitis", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Antitrust Laws and Competition Issues", "name": "subject", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}